Cargando…

Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens

OBJECTIVE: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. METHODS: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contacted...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannings, Ashley N., Michaels, Natasha M., Hiller, Debbie, Marciniak, Macary Weck, Ferreri, Stefanie P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127085/
https://www.ncbi.nlm.nih.gov/pubmed/34007561
http://dx.doi.org/10.24926/iip.v10i3.939
_version_ 1783693884024422400
author Hannings, Ashley N.
Michaels, Natasha M.
Hiller, Debbie
Marciniak, Macary Weck
Ferreri, Stefanie P.
author_facet Hannings, Ashley N.
Michaels, Natasha M.
Hiller, Debbie
Marciniak, Macary Weck
Ferreri, Stefanie P.
author_sort Hannings, Ashley N.
collection PubMed
description OBJECTIVE: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. METHODS: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contacted by community-based pharmacists during a five-month period and were informed of the availability and potential benefits of insulin pen delivery systems (IPDS). If the patient agreed to the switch, the pharmacist contacted the prescriber to obtain a new prescription. Prescription refill records were tracked for six months post-intervention to determine whether patients who were converted remained on the IPDS. RESULTS: The overall vial-to-pen conversion success rate was 26% out of 121 potential conversions. In addition, 52% of patients reached were willing to switch and prescribers approved 71% of the recommendations to switch from vial-to-pen. Of the prescriptions successfully converted to an IPDS, 84% of prescriptions were still dispensed as pen products six months following the conversion. CONCLUSION: Community-based pharmacists can serve as a resource to provide education on insulin delivery options and increase use of IPDS in patients with diabetes.
format Online
Article
Text
id pubmed-8127085
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-81270852021-05-17 Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens Hannings, Ashley N. Michaels, Natasha M. Hiller, Debbie Marciniak, Macary Weck Ferreri, Stefanie P. Innov Pharm Original Research OBJECTIVE: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. METHODS: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contacted by community-based pharmacists during a five-month period and were informed of the availability and potential benefits of insulin pen delivery systems (IPDS). If the patient agreed to the switch, the pharmacist contacted the prescriber to obtain a new prescription. Prescription refill records were tracked for six months post-intervention to determine whether patients who were converted remained on the IPDS. RESULTS: The overall vial-to-pen conversion success rate was 26% out of 121 potential conversions. In addition, 52% of patients reached were willing to switch and prescribers approved 71% of the recommendations to switch from vial-to-pen. Of the prescriptions successfully converted to an IPDS, 84% of prescriptions were still dispensed as pen products six months following the conversion. CONCLUSION: Community-based pharmacists can serve as a resource to provide education on insulin delivery options and increase use of IPDS in patients with diabetes. University of Minnesota Libraries Publishing 2019-07-08 /pmc/articles/PMC8127085/ /pubmed/34007561 http://dx.doi.org/10.24926/iip.v10i3.939 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Hannings, Ashley N.
Michaels, Natasha M.
Hiller, Debbie
Marciniak, Macary Weck
Ferreri, Stefanie P.
Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens
title Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens
title_full Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens
title_fullStr Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens
title_full_unstemmed Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens
title_short Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens
title_sort vial-to-pen: community-based pharmacists converting insulin regimens
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127085/
https://www.ncbi.nlm.nih.gov/pubmed/34007561
http://dx.doi.org/10.24926/iip.v10i3.939
work_keys_str_mv AT hanningsashleyn vialtopencommunitybasedpharmacistsconvertinginsulinregimens
AT michaelsnatasham vialtopencommunitybasedpharmacistsconvertinginsulinregimens
AT hillerdebbie vialtopencommunitybasedpharmacistsconvertinginsulinregimens
AT marciniakmacaryweck vialtopencommunitybasedpharmacistsconvertinginsulinregimens
AT ferreristefaniep vialtopencommunitybasedpharmacistsconvertinginsulinregimens